Thomas Rodgers

Thomas Rodgers
Partner, Cambia Health Solutions

Website | @tlr7777

Tom co-leads Cambia’s venture investing effort and focuses on solutions that will lower cost, improve access, and broadly help transform the sustainability of our health care system. He also helps manage Cambia portfolio of internally developed and acquired operating companies. Prior to accepting this role at Cambia, Tom was a partner at Advanced Technology Ventures, where he lead ATV’s efforts in Healthcare technology. He represented ATV on the boards of several portfolio companies including Aperio (acquired by Danaher: DHR), Helixis (acquired by Illumina: ILMN), Valeritas, PolyRemedy, Gynesonics, Zeltiq Aesthetics (NSDQ: ZLTQ) and Solar Junction. Prior to joining ATV, Tom had significant operating experience in the health care industry including various strategy, business development, sales, and marketing roles at leading technology companies. Most recently he served as VP of corporate strategy and business development at McKesson Corporation, one of the primary players in the healthcare IT and services industry. Prior to McKesson, he managed sales and healthcare strategy while earning his entrepreneurial stripes and wounds at FitLinxx, a venture-backed startup that pioneered the fitness and activity monitoring market including the technology behind the Nike+ system. Before that Tom was a Product Manager at Genentech and was responsible for the successful Nutropin™, Nutropin AQ™ and Pulmozyme™ franchises and he started his career as a consultant with The Wilkerson Group. Tom holds an M.B.A. from the Wharton School, a B.A. from the University of Pennsylvania and was an All American rugby player. He also sheepishly admits he was once the New Hampshire State high school math champion.


Healthcare Systems of the Future
Location: Grand Ballroom B
Moderated by:
Anne DeGheest (Healthtech Capital)
Alexis Borisy (Third Rock Ventures), Bryan Roberts (Venrock), Thomas Rodgers (Cambia Health Solutions)
Average rating: ***..
(3.67, 3 ratings)
There is a large unmet market need for big data solutions in healthcare. However, is there a funding gap between the medical VCs and traditional technology investors? Read more.


For information on exhibition and sponsorship opportunities at the conference, contact Sharon Pierce at (203) 304-9476 or

For information on trade opportunities with O'Reilly conferences contact mediapartners

For media-related inquiries, contact Maureen Jennings at

View a complete list of Strata Rx contacts